Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) Sees Large Growth in Short Interest

Santen Pharmaceutical Co., Ltd. (OTCMKTS:SNPHY) saw a significant growth in short interest in the month of October. As of October 30th, there was short interest totaling 2,838 shares, a growth of 1,319.0% from the October 15th total of 200 shares. Based on an average trading volume of 2,344 shares, the days-to-cover ratio is currently 1.2 days. Currently, 0.0% of the company’s shares are sold short.

Santen Pharmaceutical Stock Up 0.4%

OTCMKTS SNPHY traded up $0.06 during trading on Tuesday, hitting $12.73. The company had a trading volume of 1,894 shares, compared to its average volume of 2,256. Santen Pharmaceutical has a one year low of $9.50 and a one year high of $13.93. The company’s fifty day moving average is $11.16 and its 200-day moving average is $11.53.

Santen Pharmaceutical Company Profile

Santen Pharmaceutical is a Japan-based pharmaceutical company focused on eye care. Founded in 1890, it researches, develops, manufactures and markets treatments for ophthalmic conditions. Its products include prescription medicines for conditions such as glaucoma, dry eye and retinal diseases, as well as over-the-counter eye drops and other eye-care products. The company also offers products for eye surgery and related medical needs. Headquartered in Osaka, Santen serves patients and healthcare professionals in Japan and international markets, including other parts of Asia, Europe and the Middle East and Africa.